163 related articles for article (PubMed ID: 16507509)
21. Cross-functioning between the extraneuronal monoamine transporter and multidrug resistance protein 1 in the uptake of adrenaline and export of 5-(glutathion-S-yl)adrenaline in rat cardiomyocytes.
Costa VM; Ferreira LM; Branco PS; Carvalho F; Bastos ML; Carvalho RA; Carvalho M; Remio F
Chem Res Toxicol; 2009 Jan; 22(1):129-135. PubMed ID: 19053318
[TBL] [Abstract][Full Text] [Related]
22. The Effect of P-Glycoprotein Inhibition and Activation on the Absorption and Serum Levels of Cyclosporine and Tacrolimus in Rats.
Yigitaslan S; Erol K; Cengelli C
Adv Clin Exp Med; 2016; 25(2):237-42. PubMed ID: 27627555
[TBL] [Abstract][Full Text] [Related]
23. The complexity of intestinal absorption and exsorption of digoxin in rats.
Yao HM; Chiou WL
Int J Pharm; 2006 Sep; 322(1-2):79-86. PubMed ID: 16781832
[TBL] [Abstract][Full Text] [Related]
24. Effects of oral epigallocatechin gallate on the oral pharmacokinetics of verapamil in rats.
Chung JH; Choi DH; Choi JS
Biopharm Drug Dispos; 2009 Mar; 30(2):90-3. PubMed ID: 19226653
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetic changes of intravenous tacrolimus in rats with uranyl nitrate-induced acute renal failure.
Son IJ; Moon YJ; Lee MG; Sohn YT
Res Commun Mol Pathol Pharmacol; 2000; 108(5-6):359-68. PubMed ID: 11958289
[TBL] [Abstract][Full Text] [Related]
26. In vivo induction of hepatic p-glycoprotein by cyclosporine in the rat.
Bai S; Liu J; Lu SK; Brunner LJ
Res Commun Mol Pathol Pharmacol; 2001 Jul; 109(1-2):103-14. PubMed ID: 11458978
[TBL] [Abstract][Full Text] [Related]
27. Ex situ inhibition of hepatic uptake and efflux significantly changes metabolism: hepatic enzyme-transporter interplay.
Lau YY; Wu CY; Okochi H; Benet LZ
J Pharmacol Exp Ther; 2004 Mar; 308(3):1040-5. PubMed ID: 14634033
[TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetic and immunosuppressive effects of tacrolimus-loaded biodegradable microspheres.
Miyamoto Y; Uno T; Yamamoto H; Xiao-Kang L; Sakamoto K; Hashimoto H; Takenaka H; Kawashima Y; Kawarasaki H
Liver Transpl; 2004 Mar; 10(3):392-6. PubMed ID: 15004766
[TBL] [Abstract][Full Text] [Related]
29. Ranolazine-tacrolimus interaction.
Pierce DA; Reeves-Daniel AM
Ann Pharmacother; 2010 Nov; 44(11):1844-9. PubMed ID: 20876828
[TBL] [Abstract][Full Text] [Related]
30. In-vitro respiratory drug absorption models possess nominal functional P-glycoprotein activity.
Madlova M; Bosquillon C; Asker D; Dolezal P; Forbes B
J Pharm Pharmacol; 2009 Mar; 61(3):293-301. PubMed ID: 19222901
[TBL] [Abstract][Full Text] [Related]
31. Effects of quercetin on the pharmacokinetics of Etoposide after oral or intravenous administration of etoposide in rats.
Li X; Choi JS
Anticancer Res; 2009 Apr; 29(4):1411-5. PubMed ID: 19414395
[TBL] [Abstract][Full Text] [Related]
32. Impaired elimination of propranolol due to right heart failure: drug clearance in the isolated liver and its relationship to intrinsic metabolic capacity.
Ng CY; Ghabrial H; Morgan DJ; Ching MS; Smallwood RA; Angus PW
Drug Metab Dispos; 2000 Oct; 28(10):1217-21. PubMed ID: 10997943
[TBL] [Abstract][Full Text] [Related]
33. An up-date review on individualized dosage adjustment of calcineurin inhibitors in organ transplant patients.
Masuda S; Inui K
Pharmacol Ther; 2006 Oct; 112(1):184-98. PubMed ID: 16759707
[TBL] [Abstract][Full Text] [Related]
34. The erythromycin breath test reflects P-glycoprotein function independently of cytochrome P450 3A activity.
Kurnik D; Wood AJ; Wilkinson GR
Clin Pharmacol Ther; 2006 Sep; 80(3):228-34. PubMed ID: 16952489
[TBL] [Abstract][Full Text] [Related]
35. Influence of CYP3A5 genetic polymorphism on tacrolimus daily dose requirements and acute rejection in renal graft recipients.
Quteineh L; Verstuyft C; Furlan V; Durrbach A; Letierce A; Ferlicot S; Taburet AM; Charpentier B; Becquemont L
Basic Clin Pharmacol Toxicol; 2008 Dec; 103(6):546-52. PubMed ID: 19067682
[TBL] [Abstract][Full Text] [Related]
36. An evaluation of para toluene-sulfonamide metabolism and effect with regard to CYP isoforms, P-glycoprotein, and drug interactions.
Zhou JQ; Tang ZQ; Zhang JN
Pharmazie; 2006 Oct; 61(10):869-73. PubMed ID: 17069428
[TBL] [Abstract][Full Text] [Related]
37. Substituted tetrahydroisoquinoline compound B3 inhibited P-glycoprotein-mediated multidrug resistance in-vitro and in-vivo.
Fang W; Li Y; Cai Y; Kang K; Yan F; Liu G; Huang W
J Pharm Pharmacol; 2007 Dec; 59(12):1649-55. PubMed ID: 18053326
[TBL] [Abstract][Full Text] [Related]
38. Disposition of tacrolimus (FK 506) in rabbits. Role of red blood cell binding in hepatic clearance.
Piekoszewski W; Chow FS; Jusko WJ
Drug Metab Dispos; 1993; 21(4):690-8. PubMed ID: 7690698
[TBL] [Abstract][Full Text] [Related]
39. Differentiation of gut and hepatic first pass metabolism and secretion of saquinavir in ported rabbits.
Sinko PJ; Kunta JR; Usansky HH; Perry BA
J Pharmacol Exp Ther; 2004 Jul; 310(1):359-66. PubMed ID: 15004217
[TBL] [Abstract][Full Text] [Related]
40. Citrus grandis peel increases the bioavailability of cyclosporine and tacrolimus, two important immunosuppressants, in rats.
Lin SP; Chao PD; Tsai SY; Wang MJ; Hou YC
J Med Food; 2011 Nov; 14(11):1463-8. PubMed ID: 21883002
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
